While the control rate for uveal melanoma approaches 100%, disease-related mortality for this cancer has remained essentially unchanged over the past eight decades. According to Thomas M. Aaberg Jr., MD, identifying patients at greatest risk for metastasis and providing them with prophylactic treatment are key to altering mortality outcomes in the future.
Despite the damaging effects of ultraviolet radiation (UV) to the eyes and vision, 40% of adults in the United States say they do not wear sunglasses while outdoors.
The FDA has approved Bausch + Lomb’s Trulign lens, a toric posterior chamber IOL that corrects for astigmatism and has the capacity to deliver improved vision across a natural range of focus.
Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology.
Valeant Pharmaceuticals International Inc. and Bausch + Lomb Holdings Inc. have entered into a definitive agreement, under which Valeant will acquire Bausch + Lomb.
Senators from the Health, Education, Labor and Pensions (HELP) Committee have introduced a revised version of its draft compounding bill to help improve the safety of compounded human and animal drugs.
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking (CXL) on the limbal stem cells provide some reassurance about the safety of the technique.
Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize myopia in children.
New Jersey has enacted legislation that requires insurance companies and health plans to provide coverage for the early refill of prescription eye drops at 70% of the predicted days of use.
Survey results paint portrait of trends, technology’s effect on cataract practice
Lens demonstrated excellent rotational stability, visual outcomes in clinical trials
Corneal inlay allows presbyopia correction either paired with or after LASIK
Ian MacDonald, MSc, MD, talked about the future of gene therapy trials in choroideremia, a single-gene disorder that primarily affects the eye.
Cosmetic eyelash extensions and the adhesives used to apply them to eyelids can present dangers to consumers.
Ophthalmologists Leonard Flom, MD, and Aran Safir, MD, have been inducted into the National Inventors Hall of Fame for the invention of the iris recognition scanner.
Allegro Ophthalmics LLC and Senju Pharmaceutical Co. Ltd. have entered into a collaboration and agreement to develop and market Allegro’s integrin peptide therapy in Japan.
Once-daily dosing delivers rapid, potent control of postoperative pain, inflammation
Chemical enhancements to riboflavin solution aim to overcome need for epithelial debridement
Algorithm helps ophthalmologists decide best treatment option for patients based on data
Today’s options for patients with low vision go beyond traditional vision aids
Historical perspective captures transition from traditional to modern medicine
On the art of recommending eyeglasses to patients during the examination
Supplementation will keep the vitamin A levels above the critical threshold
Wound construction, IOL calculations, lens selection among variables in special population
On the rippling effects of alleviating suffering for free
Some older and newer treatments being studied for treating uveitis include iontophoresis, contact lenses, and nanoparticles.
Stephen J. Ryan, MD, a member of the Allergan Board of Directors, died on April 29, 2013 after a short illness.
A new PDUFA goal date has been established with the FDA for Iluvien fluocinolone acetonide implant (Alimera Sciences Inc.), and a PAS has been submitted to NICE in the United Kingdom.
